Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Open Cosmos raises €300m, no US name

2 min read
16:30UTC

Open Cosmos announced a €300 million round on 14 September drawn from a European syndicate with British state money inside it, and named no American investor anywhere in the release.

TechnologyDeveloping
Key takeaway

A profitable British satellite maker raised nine figures from a syndicate with no American name on it.

Open Cosmos, the satellite manufacturer at Harwell Campus in Didcot, announced a €300 million growth round on 14 September⁠1. The syndicate includes the UK government's National Security Strategic Investment Fund (NSSIF), the state's venture vehicle for national-security technology, alongside Lightrock, ETF Partners, Institut Catala de Finances, Entrepreneurs First, Convex Group, Phoenix Court, Claret Capital Partners and two unnamed international pension funds. No American investor appears anywhere in the release.

The company employs close to 400 people across the UK, Spain, Portugal and Greece, and reports five consecutive years of profitable growth. Money at this scale, written against a profit history rather than a forecast, has long been the cheque British founders said required a flight to Menlo Park. It arrived from Europe instead, with British state money inside it.

NSSIF carries a defence remit rather than a view on capital markets. It took a position in Greenjets alongside the NATO Innovation Fund in July on the same national-security logic, so its presence here says more about what the state counts as strategic than about the depth of European growth capital.

One caution belongs with the Headline. A company release is a marketing document and not a share register, so the absence of an American name records what Open Cosmos chose to publish rather than who holds the stock. Read against the Form S-1 that Nscale filed four days later, the pairing shows what each pool of capital will buy: Europe priced five years of profit, and New York is being asked to price a contracted book its revenue has barely begun to touch.

Deep Analysis

In plain English

Open Cosmos, a British company that builds and operates satellites, raised €300m. Unlike many big funding rounds, none of the money came from an American investor. That is unusual and probably deliberate. Companies that build technology governments care about, like satellites, sometimes avoid US investors because US rules can restrict who a company is allowed to sell to once American money or components are involved.

Deep Analysis
Root Causes

Dual-use space and defence technology sits under US International Traffic in Arms Regulations when American investors or components are involved, which can restrict export and re-export even for a foreign-built product. A syndicate with no American name keeps Open Cosmos clear of that entanglement.

That matters because NSSIF and the syndicate's other institutions are underwriting a company whose customers likely include UK and allied government bodies; ITAR exposure through the cap table can complicate exactly those contracts.

What could happen next?
  • Precedent

    An all-European, NSSIF-anchored syndicate at this size offers a template other UK dual-use space and defence-tech companies may follow to avoid ITAR exposure while still raising growth capital.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Open Cosmos· 21 Sept 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.